Ketoprofene Lp Viatris (Ketoprofen)

Ketoprofen blocks both COX‑1 and COX‑2 enzymes, which reduces the production of prostaglandins that mediate inflammation, pain, and fever. By lowering prostaglandin levels, the drug diminishes swelling and discomfort at the site of injury.

The appropriate dose of ketoprofen is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for ketoprofen during pregnancy and lactation are limited. It is generally avoided, especially in the third trimester, because of potential fetal cardiovascular effects and possible excretion in breast milk. Consultation with a healthcare provider is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoprofen and ibuprofen share a similar mechanism of COX inhibition, but ketoprofen often provides longer‑lasting analgesia and may be more potent on a milligram‑per‑milligram basis. Both carry comparable gastrointestinal and cardiovascular risks, so choice depends on clinical response, dosing convenience and individual patient tolerance.

Ketoprofen should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date indicated on the label.

Ketoprofen is administered orally, typically as tablets or capsules, and should be taken with a full glass of water. It may be taken with food or milk to reduce gastrointestinal irritation, unless the prescriber advises otherwise.

Serious risks include gastrointestinal ulceration or bleeding, severe liver injury, acute kidney failure, and rare but life‑threatening hypersensitivity reactions such as anaphylaxis. Patients should be monitored for signs of these events, especially if they have pre‑existing risk factors.

Ketoprofen is contraindicated in individuals with known hypersensitivity to ketoprofen or other NSAIDs, those with active gastrointestinal ulceration, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. It should also be used with caution in patients with cardiovascular disease.